(Q40966106)

English

Calpain inhibitor I increases beta-amyloid peptide production by inhibiting the degradation of the substrate of gamma-secretase. Evidence that substrate availability limits beta-amyloid peptide production

scientific article published on March 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Calpain inhibitor I increases beta-amyloid peptide production by inhibiting the degradation of the substrate of gamma-secretase. Evidence that substrate availability limits beta-amyloid peptide production (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

author name string

Zhang L

1

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Song L

2

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Parker EM

3

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

language of work or name

0 references

publication date

1 March 1999

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Journal of Biological Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

274

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

8966-8972

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Amyloid beta-protein and the genetics of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.13.8966

21 January 2018

Amyloid, the presenilins and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.13.8966

21 January 2018

Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.13.8966

21 January 2018

Evidence that the 42- and 40-amino acid forms of amyloid beta protein are generated from the beta-amyloid precursor protein by different protease activities

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.13.8966

21 January 2018

Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.13.8966

21 January 2018

Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.13.8966

21 January 2018

Inhibition of beta-amyloid formation identifies proteolytic precursors and subcellular site of catabolism

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.13.8966

21 January 2018

Specific increase in amyloid beta-protein 42 secretion ratio by calpain inhibition

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.13.8966

21 January 2018

Calpain inhibitor I decreases beta A4 secretion from human embryonal kidney cells expressing beta-amyloid precursor protein carrying the APP670/671 double mutation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.13.8966

21 January 2018

Cysteine proteinase inhibitors and ras gene products share the same biological activities including transforming activity toward NIH3T3 mouse fibroblasts and the differentiation-inducing activity toward PC12 rat pheochromocytoma cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.13.8966

21 January 2018

Inhibition of the chymotrypsin-like activity of the pituitary multicatalytic proteinase complex

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.13.8966

21 January 2018

Analysis of heterogeneous A4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive Western blot assay.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.13.8966

21 January 2018

Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.13.8966

21 January 2018

Membrane inserted APP fragments containing the beta A4 sequence of Alzheimer's disease do not aggregate

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.13.8966

21 January 2018

An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.13.8966

21 January 2018

Analysis of the 5' sequence, genomic structure, and alternative splicing of the presenilin-1 gene (PSEN1) associated with early onset Alzheimer disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.13.8966

21 January 2018

The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.13.8966

21 January 2018

Generation of beta A4 from the amyloid protein precursor and fragments thereof

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.13.8966

21 January 2018

Presenilin 1 is actively degraded by the 26S proteasome

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.13.8966

21 January 2018

Identifiers

10.1074/JBC.274.13.8966

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40966106&oldid=1911278870"